Hurler syndrome

Last revised by Henry Knipe on 2 Oct 2024

Hurler or Hurler-Scheie syndrome is one of the mucopolysaccharidoses (MPS type I).

The estimated incidence is ~1:100,000.

The diagnosis may be suspected with characteristic skeletal, ophthalmic, neurodevelopmental, or biochemical findings. Urine analysis may show mucopolysaccharides 4. The diagnosis is made by demonstrating α-l-iduronidase activity deficiency and raised glycosaminoglycan levels, or molecular testing showing a pathogenic α-l-iduronidase mutation 4,5.

Hurler syndrome manifests in the first years of life with intellectual disability, corneal clouding, deafness, and cardiac disease. Death usually occurs within the first decade of life, often from cardiac disease.

Hurler syndrome is a lysosomal storage disorder from abnormal mucopolysaccharide metabolism due to deficient α-l-iduronidase activity 4.

Inheritance is autosomal recessive 4.

It is named after Gertrud Hurler (1889-1965), a German pediatrician 1.

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.